...
机译:焦虑与非焦虑抑郁症患者的治疗结果差异:STAR * D报告
Maurizio Fava, M.D.A. John Rush, M.D.Jonathan E. Alpert, M.D., Ph.D.G.K. Balasubramani, Ph.D.Stephen R. Wisniewski, Ph.D.Cheryl N. Carmin, Ph.D.Melanie M. Biggs, Ph.D.Sidney Zisook, M.D.Andrew Leuchter, M.D.Robert Howland, M.D.Diane Warden, Ph.D.Madhukar H. Trivedi, M.D.Received Nov. 16, 2006, revisions received March 20, June 18, and Aug. 20, 2007, accepted Aug. 27, 2007 (doi: 10.1176/ appi.ajp.2007.06111868). From the Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, University of Illinois at Chicago, Department of Psychiatry, University of California, San Diego, and San Diego VA Medical Center, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, and the Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh. Address correspondence and reprint requests to Dr. Fava, Depression Clinical and Research Program, Massachusetts General Hospital, 55 Fruit St., Bulfinch 351, Boston, MA 02114, mfava@partners.org (e-mail).Supported by NIMH under contract N01MH90003 to University of Texas Southwestern Medical Center at Dallas (principal investigator, Dr. Rush). Medications for this trial were provided at no cost by Bristol-Myers Squibb, Forest Laboratories, GlaxoSmithKline, King Pharmaceuticals, Organon, Pfizer, and Wyeth. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U-S. Government.Dr. Fava has received research support from or served as an adviser, consultant, or speaker for Abbott Laboratories, Alkermes, Aspect Medical Systems, Astra-Zeneca, Auspex Pharmaceuticals, Bayer AG, Best Practice Project Management, Biovail Pharmaceuticals, Boehringer-lngelheim, BrainCells. Bristol-Myers Squibb, Cephalon, CNS Response. Compellis, Cypress Pharmaceuticals, Dov Pharmaceuticals, EPIX Pharmaceuticals, Fabre-Kramer Pharmaceuticals, Forest Pharmaceuticals, GlaxoSmithKline, Grunenthal GmbH, Janssen Pharmaceutica, Jazz Pharmaceuticals. Johnson & Johnson Pharmaceuticals, Knoll Pharmaceutical Company, Lichtwer Pharma GmbH, Eli Lilly, Lorex Pharmaceuticals, Lundbeck, MedAvante, Merck, Neuronetics, Novartis, Nutrition 21, Organon, PamLab, Pfizer, PharmaStar, Pharmavite, Pfizer, Precision Human Biolaboratory, Roche, Sanofi/Synthelabo. Sepracor, Solvay, Somaxon, Somerset Pharmaceuticals, Takeda. TetraGenex, Transcept Pharmaceuticals, and WyethAyerst, he also holds equity in Compellis and MedAvante. Dr. Rush has received research support from or served as an adviser, consultant, or speaker for Advanced Neuromodulation Systems, Best Practice Project Management, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Pharmaceuticals. Gerson Lehman Group, GlaxoSmithKline, Healthcare Technology Systems, Jazz Pharmaceuticals. Merck, Neuronetics, NIMH, Ono Pharmaceuticals, Organon, Personality Disorder Research Corp.. Robert Wood Johnson Foundation, Stanley Medical Research Institute. Urban Institute, and Wyeth-Ayerst, he also receives royalties from Guilford Publications and Healthcare Technology Systems and holds stock in Pfizer, Dr. Alpert has received research support from or served as an adviser, consultant, or speaker for Abbott Laboratories, Alkermes. Lichtwer Pharma GmbH, Lorex Pharmaceuticals Aspect Medical Systems. Astra-Zeneca, Bristol-Myers Squibb. Cephalon. Cyberonics, Eli Lilly. Forest Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals. Novartis, Organon. PamLab. Pfizer, Pharmavite. Roche. Sanofi/Synthelabo, Solvay, and Wyeth-Ayerst. Dr. Wisniewski has consulted for Cyberonics. ImaRx Therapeutics, Bristol-Myers Squibb, and Organon. Dr. Biggs has consulted for Bristol-Myers Squibb. GlaxoSmithKline, Eli Lilly, Merck, and Pfizer. Dr. Zisook has received research support from or served as an adviser, consultant, or speaker for Aspect Medical Systems, Forest Laboratories. GlaxoSmithKline, PamLab. NIMH, and Veterans Administrative Health Care. Dr. Leuchter has received research support from or served as an adviser, consultant, or speaker for Aspect Medical Systems, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, MEDACorp, MedAvante, Merck. Novartis, Pfizer, Shire. Vivometrics, and Wyeth, and he holds equity in Aspect Medical Systems. Dr. Howland has received research support from or served as a speaker for Aspect Medical Systems. AstraZeneca, Eli Lilly. Organon. Bristol-Myers Squibb, Cyberonics, National Center for Complementary and Alternative Medicine. NIH, and Wyeth. Dr. Warden has received research support from NIMH and holds equity in Bristol-Myers Squibb and Pfizer. Dr. Trivedi has received research support from or served as an adviser, consultant, or speaker for Abbott Laboratories. Abdi Brahim, Akzo (Organon), AstraZeneca. Bayer. Bristol-Myers Squibb. Cephalon, Corcept Therapeutics. Cyberonics, Fabre-Kramer, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica. Johnson & Johnson PRD, Eli Lilly, Meade Johnson, Merck. National Alliance for Research in Schizophrenia and Depression, NIMH, Neuronetics, Novartis, Organon. Parke-Davis, Pfizer, Pharmacia & Upjohn. Predix Pharmaceuticals, Sepracor. Solvay. VantagePoint. and Wyeth-Ayerst. Drs. Balasubramani and Carmin report no competing interests.,;
机译:焦虑与非焦虑抑郁症患者的治疗结果差异:STAR * D报告。
机译:患有抗焦虑药和非抗焦虑药的中国人群缓解症状的差异:OPERATION研究报告
机译:门诊焦虑与非焦虑抑郁患者急性期认知治疗的结果
机译:常规数据分析以比较关门抑郁症治疗方案
机译:在特拉华州指导服务密集门诊计划中,对接受治疗的患者进行人口统计学,家族特征和临床因素差异调查。
机译:门诊焦虑与非焦虑抑郁患者急性期认知治疗的结果
机译:急性期认知疗法在急性期与急性抑郁症的结果